LAVIV™ (Azficel-T) is now Available at Strimling Dermatology, Laser & Vein Institute of Las Vegas
– First and Only FDA-Approved Wrinkle Treatment Made from Your Own Collagen-Producing Skin Cells –
Las Vegas, NV, 4/28/2012 – Strimling Dermatology, Laser & Vein Institute of Las Vegas is now offering LAVIV™ (Azficel-T), the first and only personalized cell therapy approved by the FDA for aesthetic use
to improve the look of smile line wrinkles in adults. LAVIV is only available in select cities
through board-certified dermatologists and plastic surgeons, such as Dr. Stirmling who has completed the comprehensive training program required by Fibrocell Science, Inc., the product manufacturer.
Fibroblasts are responsible for producing collagen, which helps give skin its tone, structure
and overall quality. As people age, the number of fibroblasts in their skin decreases and
collagen breaks down, resulting in wrinkles and lost skin tone. The patented technology behind LAVIV
is an advanced process that extracts a person’s fibroblast cells from a small skin sample and
multiplies them in the Fibrocell Science lab. LAVIV is the resulting formulation of a person’s own fibroblast cells, which is then injected into smile line wrinkles.
“Being able to offer this breakthrough treatment to my patients is exciting because LAVIV is made just
for them,” said Dr. Stirmling. “LAVIV is truly unique because each patient is being injected
with their own collagen-producing fibroblast cells.”
The recommended course of LAVIV administration is a series of three treatments,
typically three to six weeks apart. Each person’s formulation of LAVIV is unique because it is made
from their own collagen-producing fibroblast cells.
Important Safety Information
LAVIV is made especially for you from your own skin cells.
Using someone else’s cells can cause a serious reaction. Prior to injection,
confirm with your physician that your information on the LAVIV vial is correct.
The most common side effects of LAVIV are at the injection-site, including redness, bruising, swelling, pain, bleeding, lumps, irritation, and itchiness. In clinical trials with LAVIV, most injection-site adverse reactions resolved within one week and most required no treatment.
Your health care provider will help you to decide whether you are a candidate for LAVIV and may help you avoid some of the adverse reactions from LAVIV. Before getting LAVIV, tell your healthcare provider
if you have any medical problems including allergic reactions to any drugs or food, bleeding disorders or take blood-thinning medicines like aspirin, ibuprofen, or coumadin, keloids or excessive scarring,
skin cancer or any malignancy, genetic disorders affecting your skin, immune problems or take medicines that affect your immune system, or any other illness or medical problem. The full Prescribing Information for LAVIV includes additional warnings about adverse reactions that occurred in less than 1% of patients following LAVIV treatment in clinical trials. Talk to your healthcare provider about these warnings.
Please tell your healthcare provider if you are allergic to the antibiotics amphotericin or gentamicin, bovine materials (products made from cattle), or dimethyl sulfoxide (DMSO). Do not use LAVIV if you have a skin infection on your face because LAVIV treatment can make the infection worse.
For more information about LAVIV, please see the Full Prescribing Information at www.mylaviv.com.
Strimling Dermatology, Laser & Vein Institute
10105 Banburry Cross Drive, Suite 350
Las Vegas, NV 89144
(702) 243-6400 (#)